Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ALINIA

NITAZOXANIDE

Standard Dose
100MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ALINIA is listed in Drugs@FDA under application 021498 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NITAZOXANIDE Form and strength FOR SUSPENSION;ORAL - 100MG/5ML Sponsor ROMARK Submission history Latest submission status date: 2022-01-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALINIA is listed in Drugs@FDA under application 021498 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NITAZOXANIDE Form and strength FOR SUSPENSION;ORAL - 100MG/5ML Sponsor ROMARK Submission history Latest submission status date: 2022-01-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.